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finally, and probably most intriguingly, these studies the transcriptional modulatory role of NAD linked to its
point to NAD as a modulator of gene expression. NAD role in cellular metabolism and possibly also aging as
first came onto the transcriptional scene when Guarente postulated for Sir2? Questions such as these have al-
and coworkers reported that the Sir2 transcriptional si- ways kept molecular biologists and biochemists study-
lencing protein was an NAD-dependent histone deacet- ing transcription and chromatin regulation busy. The
ylase, linking cellular NAD levels to transcriptional func- difference now is that enzymologists, structural biolo-
tion [6]. More recently, McKnight and coworkers have gists, and cell biologists can also join the party.
reported that the DNA binding activity of the hetero-
dimeric Clock/NPAS2 transcriptional regulator is modu-
Ronen Marmorsteinlated by the redox state of NAD cofactors [7]. Interest-
The Wistar Institute and Department of Chemistryingly, CtBP and Sir2 show a similar overall architecture
University of Pennsylvaniain which both proteins contain a topologically similar
Philadelphia, Pennsylvania 19104NAD binding domain (parallel six-stranded  sheet with
helices on both sides of the sheet) that is connected
Selected Readingthrough a series of loops to a putative substrate specific-
ity domain [8–10]. Despite similar architectures, the pro- 1. Brownell, J.E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson,
teins do not superimpose well and the NAD cofactor D.G., Roth, S.Y., and Allis, C.D. (1996). Cell 84, 843–851.
is bound in dramatically different configurations (see 2. Berger, S.L. (2001). Oncogene 20, 3007–3013.
3. Kumar, V., Carlson, J.E., Ohgi, K.A., Edwards, T.A., Rose, D.W.,Figure). Together, this suggests that NAD may bind and
Escalante, C.R., Rosenfeld, M.G., and Aggarwal, A.K. (2002).signal transcriptional regulators in different ways.
Mol. Cell 10, 857–869.While these exciting findings on CtBP add new in-
4. Turner, J., and Crossley, M. (2001). Bioessays 23, 683–690.
sights, they also raise new questions. With regard to 5. Zhang, Q., Piston, D.W., and Goodman, R.H. (2002). Science
CtBP, an obvious question is: what is the actual cellular 295, 1895–1897.
substrate of CtBP and how does the dehydrogenase 6. Imai, S., Armstrong, C.M., Kaeberlein, M., and Guarente, L.
activity of CtBP modulate RNA transcription and possi- (2000). Nature 403, 795–800.
7. Rutter, J., Reick, M., Wu, L.C., and McKnight, S.L. (2001). Sci-bly also chromatin regulation? A broader question is:
ence 293, 510–514.will there be more examples of a direct link between
8. Finnin, M.S., Donigian, J.R., and Pavletich, N.P. (2001). Nat.enzymatic activity and induced fit protein-protein inter-
Struct. Biol. 8, 621–625.
actions as proposed for CtBP? Finally, is NAD a key 9. Min, J., Landry, J., Sternglanz, R., and Xu, R.M. (2001). Cell 105,
signaling molecule for transcription and chromatin regu- 269–279.
lation, the same way in which guanine nucleotides are 10. Avalos, J.L., Celic, I., Muhammad, S., Cosgrove, M.S., Boeke,
J.D., and Wolberger, C. (2002). Mol. Cell 10, 523–535.signaling molecules for G-coupled receptors? If so, is
side of the pyranose ring, an aspartic acid, D1, is close to
the glycosidic oxygen atom of Neu5Ac and is implicated
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The Trypanosomal Trans-Sialidase:
Two Catalytic Functions (directly or via a water molecule) in hydrolysis; and
Neu5Ac binding results in the carboxylate becomingAssociated with One Catalytic Site
equatorial, with the pyranose ring in a twist boat confor-
mation. Furthermore, the catalytic site appears to be
structurally prepared for catalysis, at least in the sense
that no significant protein structural change accompan-The structure of the trypanosomal trans-sialidase re-
ies binding of either sialic acid or the transition stateveals a canonical sialidase catalytic site elaborated
analog (see Table). The catalytic sites of these differentwith a conformational switch that creates an adjacent
sialidases are variable in their binding interactions withbinding pocket for lactose.
elements of the substrate that are farther removed from
the hydrolyzable glycosidic bond (namely, the 4-hydroxyl-,
Three-dimensional structures of sialidases (neuramini- N-acetyl-, and glycerol substituents of Neu5Ac). Al-
dases) from influenza viruses, several bacterial sources, though some of these sialidases show preference for
leech, and a trypanosome have been known for some either -2,6 or -2,3 linkages, in no case has the aglycon
time [1–3], and although the catalytic parameters vary galactose been observed bound to the enzyme.
significantly, a common structural theme is evident (see The trypanosomal trans-sialidase (TS) is different in
Figure). All structures are six-bladed propellers; a clus- that it has two enzyme activities. In addition to removing
ter of three arginyl residues, R1, R4, and R5, form a pocket terminal Neu5Ac from oligosaccharide chains, it can
for the carboxylate moiety of sialic acid (Neu5Ac), which transfer the reaction product Neu5Ac to an acceptor
binds close to the propeller axis; a tyrosyl residue Y6 substrate, such as lactose. Now, in the October issue
(hydrogen bonded to a glutamate E4) is in van der Waals of Molecular Cell, structural studies of the Trypanosoma
contact with the C2 atom of Neu5Ac (3.1 A˚) and in cruzi TS by Alzari and coworkers begin to show how
short contact with that same atom of the bound transi- this is achieved by elaboration of an archetypal sialidase
active site.tion state analog Neu5Ac2en (2.8 A˚); on the solvent
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Conserved Catalytic Residues of Sialidases
and Bound Sialic Acid
Amino acids are labeled according to which
of the six sheets of thepropeller they attach.
In influenza type A viruses, R1 is R118, D1 is
D151, E4 is E277, R4 is R292, R5 is R371, and
Y6 is Y406. Although not a catalytic residue, E1
(E119) is also shown here, in semitransparent
format. It is a conserved feature of influenza
sialidase active sites, being part of the tripep-
tide sequence REP in the first  sheet of the
propeller, but is replaced by RIP or RLP in
other sialidase sequences.
While the T. cruzi trans-sialidase has all the elements on the solvent-exposed face of sialic acid to create the
binding site for lactose.typical of sialidases, it has more, but not so much more,
More conformational changes are observed when sia-as to involve a second catalytic site. By comparing its
lic acid binds to the enzyme. Specifically, on the proteinstructure with that of the previously described T. rangeli
side of the bound sugar, Y342 (Y6; see Figure) alsosialidase, some interesting differences emerge. In the
switches its conformation upon sialic acid binding. Inabsence of ligands, the trans-sialidase enzyme active
four crystallographically independent structures, thesite is partially occluded by Y119, one of the amino acids
distance between the hydroxyl oxygen of Y342 and thethat are altered with respect to T. rangeli sialidase. When
carboxylate of E230 (E4; see Figure) is observed to beNeu5Ac2en is bound, Y119 is displaced to one of two
long (3.6 A˚). In complexes with Neu5Ac2en, two tyro-alternate positions. One position is inside the active site,
sine conformers are observed, one where this distanceclose to the glycerol moiety of the bound analog. The
is also long (4.2 A˚; i.e., clearly not hydrogen bonded)other position is outside the catalytic site where, with
and one where it is short (2.5 A˚). Alzari and coworkersW312, it creates a slot-like cavity. In the absence of
propose [4] that these conformers, referred to here assialic acid, no binding of lactose to the enzyme is detect-
“long” and “short,” represent, respectively, inactive andable. But when sialic acid and lactose are soaked to-
active forms of the enzyme, presumably for both reac-gether into crystals, both the transition state analog and
tions. In the long conformer, Y342 is in a position tolactose are observed, the former in canonical interac-
effectively block binding of Neu5Ac2en because of thetions with the sialidase site and the latter in the slot
extremely short (less than 2 A˚) contact that it wouldbetween Y119 and W342. The galactose moiety is lo-
require. In the short conformer, the tyrosyl oxygencated correctly either for accepting sialic acid in the
makes a canonical short approach to C2 of the analogtransferase reaction or for departure from sialic acid in
(quoted at 2.5–2.8 A˚ [4]). It is not clear whether the analogthe cleavage reaction. The lactose binding site appears
is observed at full or partial occupancy in the reportedtoo narrow to accommodate simultaneously the aglycon
complex. Fully occupied ligand would suggest interest-moiety of the sialidase substrate and the acceptor moi-
ing and novel mechanistic possibilities relating to theety of the transferase reaction. Either these entities are
very short contact with Y342 in the long position.engaged sequentially or further structural changes oc-
In contrast with these observations are the structurescur in the lactose binding site. Thus, the conformational
of influenza virus and bacterial neuraminidases wherechange in Y119 modulates the structural environment
the two carboxylate oxygens of the “catalytic” glutamate
(E4) are 2.6 A˚ and 3.2 A˚, respectively from the tyrosyl
(Y6) oxygen in both the liganded and unliganded struc-Table 1. Effect of Ligand Binding on the 3D Structures of
tures. Exactly how conformational variability of Y6 in theSialidases and on the Paramyxovirus Bifunctional
trans-sialidase contributes to bifunctionality is unclear,Haemagglutinin-Neuraminidase (HN)
but movement of this tyrosine is “felt” by the neighboring
Sialidase Ligand Complex Native Rmsd (A˚) residue L36, the structural analog of E1 (see Figure).
Influenza A virus Neu5Ac 1MWE 7NN9 0.23 Here we compare the structures of the active sites of
Influenza A virus Neu5Ac2en 1F8B 7NN9 0.20 five sialidases with and without sialic acid-based ligands
S. typhimurium Neu5Ac2en 2SIM 3SIL 0.40 and observe root-mean-square deviations of 0.20–0.40 A˚
M. viridifaciens Neu5Ac2en 1EUS 1EUR 0.21
(see Table). The structure of the sialidase from T. rangeliLeech Neu5Ac2en 1SLI 1SLL 0.23
is reportedly also unaltered by binding of sialic acid [3].Paramyxovirus
Also shown are the comparisons for the haemagglutinin-HN Neu5Ac* 1E8U 1E8T 0.63
Paramyxovirus neuraminidase (HN) of Newcastle disease virus [5]. The
HN Neu5Ac2en 1E8V 1E8T 1.61 HN viral glycoprotein has both ligand binding (haem-
agglutinin) and cleavage (neuraminidase) activities thatRelevant PDB ID codes are shown [10].
appear to be associated with a single site that switchesRmsd of all (nonhydrogen) atoms in all residues within 10 A˚ of the
ligand. between two conformational states. Curiously, HN is
* In this complex, Neu5Ac is observed as the -anomer in the chair observed to bind -sialic acid, and not the -anomer, as
conformation, whereas all other Neu5Ac complexes are seen as the observed in all other sialidase structures. Furthermore,
-anomer in the twist boat conformation.
-sialic acid binds to HN without structural alteration of
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the HN site, but binding of the transition state analog Peter M. Colman and Brian J. Smith
Walter and Eliza Hall Institute of Medical Researchtriggers major changes (see Table). In particular, Y6
(Y526 in that structure) is one of the residues associated 1G Royal Parade
Parkville, Victoria 3050with the functional switch, and its movement also
causes rearrangement of I175, the structural analog of Australia
E1 in the Figure. Thus, unlike the enzymes with sialidase
Selected Readingactivity only, both HN and TS appear to utilize conforma-
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structural requirement of maintaining the integrity of the
conformational switch. The discovery of TS inhibitors that
are drug candidates is required to test this prediction.
In the last 5 years, tremendous insight into antigen
recognition has been gained through the determinations
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A T Cell Receptor Goes Public
of structures of a number of TCRs complexed to pep-
tide-MHC, in both mouse and human systems (1, 2).
The crystal structure of a human T cell receptor, which These initial structures solved a number of longstanding
is used almost exclusively in the immune response to global questions, such as the diagonal TCR/pMHC
an Epstein-Barr virus protein, highlights the impor- docking orientation, which appears to be conserved, to
tance of noncontact residues in antigen recognition. some degree, across all TCR/pMHC interactions. While
these early structural revelations were dramatically in-
formative, most fundamental questions about T cell rec-The cellular branch of immune surveillance is governed
by the recognition of major histocompatibility complex ognition still await more detailed structural studies. One
of these questions concerns the phenomenon of “bias”(MHC)-bound peptide antigens by  T cell receptors
(TCR) on T cells. As for antibodies, the TCR is assembled in a given TCR response to antigen. Certain antigens
elicit only a very limited set of TCR sequences, whichcombinatorially from a vast array of  and  chain vari-
able region genes that endow it with an almost limitless recognize it as a processed peptide in the context of
MHC, rather than a broad and diverse set of  TCRpotential for diversity. In particular, most of this se-
quence variation is concentrated in centrally located sequences (3). The assumption has been that the sol-
vent-exposed peptide antigen recruits highly specificcomplementarity-determining region-3 (CDR3) antigen
binding loops, where diversity is amplified at the junc- TCR contact residues that reappear within the context
of different TCR  chain combinations to achieve rec-tions of the Variable (V) gene segments with the Diversity
(D) and Joining (J) regions, along with nonnucleotide ognition. However, since a structure of a highly biased
TCR has not yet been reported, the underlying molecularencoded additions (N- and P-additions). For a given
antigen, many different TCR sequences can be pro- basis for these biases has remained speculative.
In this issue of Structure, Kjer-Nielsen et al. report theduced which are equally effective at recognizing a single
peptide-MHC complex (pMHC). In fact, in a normal im- high-resolution crystal structure of a “public” human 
TCR that is almost invariant in the response of HLA-Bmune response to antigen, one usually finds that no
one, individual TCR sequence dominates the population individuals to Epstein-Barr virus EBNA 3 antigen (4). EBV
is a very prevalent member of the herpesvirus family,of T cells directed at the invading pathogen.
